NL

NewLink Genetics

- NASDAQ:NLNK
  • NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

  • Locations

    • Ames IA

  • Total Funding (USD)

    17.0 million

  • Industries

    Software, Mobile Apps, Video Games, Cyber Security, Internet

  • Security

    Type: ORD
    CUSIP: 55028X109
    ISIN: US55028X1090
Filter date
All
Bookmark Created by Last updated
Pharmaceutical / Bioscience (Government Contracts) aconstantin.old 2019-07-08
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo